To examine if TSHR could serve as a potential target antigen for CAR‐T cell therapy in thyroid cancer, a detailed evaluation of the TSHR expression levels in normal human tissues and thyroid carcinoma samples was conducted. The gene discussed is TSHR; the disease is thyroid cancer.